{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:40:08Z","timestamp":1792978808889,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Japan Society for the Promotion of Science KAKENHI Grant","award":["JP24K10496"],"award-info":[{"award-number":["JP24K10496"]}]},{"name":"the Promotion of Science KAKENHI Grant","award":["JP24H00068"],"award-info":[{"award-number":["JP24H00068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Alpha-synuclein (\u03b1-synuclein), a key component of Lewy body pathology, is a classical hallmark of Parkinson\u2019s disease. In previous studies, our group has examined dopaminergic neuron-specific <jats:italic>Atg7<\/jats:italic> autophagy-deficient mice, observing \u03b1-synuclein aggregation in vivo. This pathological process led to dopamine neuron loss and age-related motor impairments. Further, in a recent study, we developed a new mouse model by crossing human \u03b1-synuclein bacterial artificial chromosome transgenic mice with dopaminergic neuron-specific <jats:italic>Atg7<\/jats:italic> conditional knockout mice to further investigate these mechanisms. These model mice exhibited accelerated Lewy body-like pathology and motor dysfunction, providing additional evidence that autophagy deficiency exacerbates synuclein toxicity in vivo. This nano-review provides essential clues that autophagy deficiency in dopamine neurons may contribute to the onset of human synuclein diseases.<\/jats:p>","DOI":"10.1186\/s13041-025-01235-5","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:14:19Z","timestamp":1753337659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling the mystery: How autophagy deficiency in dopaminergic neurons drives human Parkinson\u2019s disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Sachiko","family":"Noda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"1235_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in lewy bodies. Nature. 1997;388:839\u201340.","journal-title":"Nature"},{"key":"1235_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","volume":"6","author":"B Levine","year":"2004","unstructured":"Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004;6:463\u201377.","journal-title":"Dev Cell"},{"key":"1235_CR3","doi-asserted-by":"publisher","first-page":"25009","DOI":"10.1074\/jbc.M300227200","volume":"278","author":"JL Webb","year":"2003","unstructured":"Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC. Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem. 2003;278:25009\u201313.","journal-title":"J Biol Chem"},{"key":"1235_CR4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.cell.2007.10.035","volume":"131","author":"M Komatsu","year":"2007","unstructured":"Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007;131:1149\u201363.","journal-title":"Cell"},{"key":"1235_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2353\/ajpath.2009.080928","volume":"175","author":"WH Yu","year":"2009","unstructured":"Yu WH, Dorado B, Figueroa HY, Wang L, Planel E, Cookson MR, et al. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. Am J Pathol. 2009;175:736\u201347.","journal-title":"Am J Pathol"},{"key":"1235_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nature04723","volume":"441","author":"M Komatsu","year":"2006","unstructured":"Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441:880\u20134.","journal-title":"Nature"},{"key":"1235_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4161\/auto.7.6.14943","volume":"7","author":"BJ Bartlett","year":"2011","unstructured":"Bartlett BJ, Isakson P, Lewerenz J, Sanchez H, Kotzebue RW, Cumming RC, et al. p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. Autophagy. 2011;7:572\u201383.","journal-title":"Autophagy"},{"key":"1235_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0079-6123(10)84004-X","volume":"184","author":"I Magen","year":"2010","unstructured":"Magen I, Chesselet MF. Genetic mouse models of parkinson\u2019s disease the state of the Art. Prog Brain Res. 2010;184:53\u201387.","journal-title":"Prog Brain Res"},{"key":"1235_CR9","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1038\/s41598-018-21325-w","volume":"8","author":"S Sato","year":"2018","unstructured":"Sato S, Uchihara T, Fukuda T, Noda S, Kondo H, Saiki S, et al. Loss of autophagy in dopaminergic neurons causes lewy pathology and motor dysfunction in aged mice. Sci Rep. 2018;8:2813.","journal-title":"Sci Rep"},{"key":"1235_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.neures.2012.03.010","volume":"73","author":"H Yamakado","year":"2012","unstructured":"Yamakado H, Moriwaki Y, Yamasaki N, Miyakawa T, Kurisu J, Uemura K, et al. alpha-Synuclein BAC Transgenic mice as a model for parkinson\u2019s disease manifested decreased anxiety-like behavior and hyperlocomotion. Neurosci Res. 2012;73:173\u20137.","journal-title":"Neurosci Res"},{"key":"1235_CR11","doi-asserted-by":"publisher","first-page":"151514","DOI":"10.1016\/j.bbrc.2025.151514","volume":"758","author":"S Noda","year":"2025","unstructured":"Noda S, Sato S, Yamakado H, Takahashi R, Hattori N. Enhanced alpha-synuclein pathology and exacerbated motor dysfunction in alpha-synuclein Transgenic mice with autophagy deficiency. Biochem Biophys Res Commun. 2025;758:151514.","journal-title":"Biochem Biophys Res Commun"},{"key":"1235_CR12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1083\/jcb.201003122","volume":"190","author":"AR Winslow","year":"2010","unstructured":"Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, et al. alpha-Synuclein impairs macroautophagy: implications for parkinson\u2019s disease. J Cell Biol. 2010;190:1023\u201337.","journal-title":"J Cell Biol"},{"key":"1235_CR13","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","volume":"288","author":"SA Tanik","year":"2013","unstructured":"Tanik SA, Schultheiss CE, Volpicelli-Daley LA, Brunden KR, Lee VM. Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy. J Biol Chem. 2013;288:15194\u2013210.","journal-title":"J Biol Chem"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-025-01235-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-025-01235-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-025-01235-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T20:45:45Z","timestamp":1757277945000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-025-01235-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1235"],"URL":"https:\/\/doi.org\/10.1186\/s13041-025-01235-5","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}